DBU/LiCl-Assisted Nucleophilic Substitution
J . Org. Chem., Vol. 63, No. 16, 1998 5401
Appropriate fractions were combined and concentrated under
reduced pressure.
(m, 1H, H4′), 4.95 (m, 1H, H3′), 6.3 (t, 6.1, 12.8, 1H, H1′); HR
FAB-MS found [M - H] 785.270 (calcd 785.274). SLOW-
1
(RP ,SP )-5′-O-DMT-t h ym id in e 3′-O-(m et h a n ep h osp h o-
n oth ioa n ilid a te) (6) was obtained from 5′-O-DMT-thymidine
(0.54 g, 1 mmol) as a colorless foam, total yield 93% (0.66 g).
(SP ): yield 40%; 31P NMR δ 29.95; H NMR δ 1.56 (d, 15.6,
3H, PCH3), 2.28 (m, 1H, H2′), 2.50 (m, 1H, H2′′), 3.31 (m, 2H,
H5′, H5′′), 4.15 (m, 1H, H4′), 4.94 (m, 1H, H3′), 6.15 (dd, 7.1,
13.7, 1H, H1′); HR FAB-MS found [M - H] 785.270.
1
F AST-(RP ): yield 45%; 31P NMR δ 79.43; H NMR δ 2.04 (d,
15.3, 3H, PCH3) 2.37 (m, 2H, H2′, H2′′), 3.53 (m, 2H, H5′, H5′′),
4.41 (d, 1.4, 1H, H4′), 5.27 (d, 9.4, 1H), 6.36 (dd, 6.8, 6.8, 1H,
H1′); FAB-MS found [M - H] 712.3 (calcd 712.225). SLOW-
Gen er a l P r oced u r e for P r ep a r a tion of Dia ster eom er i-
ca lly P u r e (RP )- a n d (SP )-5′-O- DMT-(N-p r otected )-2′-
d eoxyn u cleosid e 3′-O-(Se-Meth yl m eth a n ep h osp h on ose-
len ola te)s (4′) or S-Meth yl Meth a n ep h osp h on oth iola tes
(5). To a stirred solution of corresponding 6 or 9 [1 mmol,
dried twice by coevaporation with dry toluene (5 mL)] in DMF
(10 mL) was added NaH (1.2 molar equiv of 50% suspension
in mineral oil) in a few portions. Stirring was continued until
evolution of hydrogen had ceased, and then a stream of gaseous
CO2 (dried over P2O5) was passed through the slurry for ca. 4
h. The resulting sodium salt of the corresponding nucleoside
3′-O-methanephosphonoselenoic(thioic) acid was treated with
MeI (5 equiv), and the progress of alkylation was followed by
TLC. Upon completion of the reaction, solvents and excess
MeI were removed by evaporation under reduced pressure. The
solid residue was dissolved in CHCl3 (20 mL) and washed twice
with saturated NaHCO3. The combined organic layers were
dried over anhydrous MgSO4 and concentrated. Ester 4′ or 5
was purified and separated into (RP)- and (SP)-diastereomers
by silica gel column chromatography (Kieselgel 60, 230-400
mesh, 3 g of 5 per 90 g of silica gel). The appropriate fractions,
eluted with CHCl3-EtOH (1-5% EtOH), were combined and
evaporated under reduced pressure.
1
(SP ): yield 30%; 31P NMR δ 79.58; H NMR δ 2.01 (d, 15.3,
3H, PCH3), 2.42 (m, 4.2, 2.9, 1H, H2′), 2.73 (m, 1H, H2′′), 3.29
(dd, 2.6, 10.6, 1H, H5′), 3.17 (dd, 2.6, 10.7, 1H, H5′′), 4.17 (d,
1.9, 1H, H4′), 6.48 (dd, 9.1, 9.0, 1H, H1′); FAB-MS found [M
- H] 712.3.
5′-O-DMT-N4-ben zoyl-2′-d eoxycytid in e 3′-O-m eth a n e-
p h osp h on oth ioa n ilid a te (6) was obtained from 5′-O-DMT-
N4-benzoyl-2′-deoxycytidine (0.633 g, 1 mmol). A mixture of
diastereomers (about 1:1 ratio) was obtained as a colorless
foam, total yield 70% (0.56 g). F AST-(RP ): yield 28%; 31P
NMR δ (CH2Cl2/C6D6) 79.33, 1H NMR δ 2.05 (d, 15.3, 3H,
PCH3), 2.27 (dd, 6.5, 13.7, 1H, H2′), 2.77 (dd, 5.1, 11.7, 1H,
H2′′), 3.54 (dd, 2.54, 11.1, 1H, H5′), 3.60 (dd, 3.2, 11.1, 1H,
H5′′), 4.59 (m, 2.4, 1H), 6.36 (dd, 6.6 6.2, 1H, H1′); FAB-MS
found [M - H] 801.3 (calcd 802.590). SLOW-(SP ): yield 32%;
1
31P NMR δ (CH2Cl2/C6D6) 79.84; H NMR δ 2.02 (d, 15.3, 3H,
PCH3); FAB-MS found [M - H] 801.3.
(RP ,SP )-5′-O-DMT-N4-b en zoyl-2′-d eoxycyt id in e 3′-O-
m eth a n ep h osp h on oselen oa n ilid a te (9) was obtained from
5′-O-DMT-N4-benzoyl-2′-deoxycytidine (0.633 g, 1 mmol).
A
mixture of diastereomers (1:1.2 ratio) was obtained as a
5′-O-P x-th ym id in e 3′-O-(S-Meth yl m eth a n ep h osp h o-
n oth iola te) (5). SLOW-(RP) was obtained from F AST-6 (R
) Px, B ) Thy): yield 86%; 31P NMR δ 57.76; 1H NMR δ 1.81
(d, 15.6, 3H, PCH3), 2.29 (d, 13.2, 3H, SCH3), 2.45 (m, 1H, H2′),
2.57 (m, 1H, H2′′), 3.47 (m, 2H, H5′, H5′′), 4.38 (d, 1.2, 1H,
H4′), 5.29 (m, 1H, H3′), 6.46 (dd, 5.4, 8.9, 1H, H1′); FAB-MS
found [M - H] 606.1 (calcd). F AST-(SP ) was obtained from
SLOW-6 (R ) Px, B ) Thy): yield 80%; 31P NMR δ 58.61; 1H
NMR δ 1.82 (d, 15.7, 3H, PCH3), 2.18 (d, 3H, SCH3), 2.45 (m,
1H, H2′), 2.62 (m, 1H, H2′′), 3.44 (m, 2H, H5′, H5′′), 4.18 (d,
1.9, 1H, H4′), 5.34 (m, 1H, H3′), 6.47 (dd, 5.6, 8.7, 1H, H1′);
FAB-MS found [M - H] 606.1.
colorless foam, total yield 70% (0.56 g). F AST-(RP ): yield 30%;
1
1
31P NMR δ 76.65, J P-Se ) 820 Hz; H NMR δ 2.06 (d, 14.8,
3H, PCH3), 2.3 (m, 1H, H2′), 2.55 (m, 1H, H2′′), 3.41 (dd, 2.4,
10.7, 1H, H5′), 3.32 (dd, 2.5, 10.6, 1H, H5′′), 4.15 (m, 1H), 5.5
(m, 1H), 6.45 (m, 1H, H1′); FAB-MS found [M - H] 849.4
(80Se) (calcd 849.5). SLOW-(SP ): yield 25%; 31P NMR δ 76.29
1
(1J P-Se ) 820 Hz); H NMR δ 1.96 (d, 13.54, 3H, PCH3), 2.37
(m, 1H, H2′), 2.5 (m, 1H, H2′′), 2.94 (dd, 2.5, 10.5, 1H, H5′),
3.1 (dd, 3.0, 10.5, 1H, H5′′), 4.35 (m, 1H,), 5.25 (m, 1H), 6.38
(m, 1H, H1′); FAB-MS found [M - H] 849.4 (80Se).
Gen er a l P r oced u r e for P r ep a r a t ion of 5′-O-DMT-
n u cleosid e 3′-O-Meth a n ep h osp h on oa n ilid a tes (8) fr om
Meth a n ep h osp h on od ich lor id a te. To a solution of MeP(O)-
Cl2 (2 mmol) in dry pyridine (15 mL) was added a solution of
5′-O-DMT-nucleoside (1 mmol) in pyridine (5 mL). The
reaction mixture was stirred at room temperature for 15 min,
and aniline (5 mmol, 0.465 g) was added. After the reaction
was completed (30 min), all solvents and reagents were
evaporated to ca. 1/3 volume.
The residue was dissolved with CHCl3 (20 mL) and extracted
with citric acid (0.05 M, 10 mL, three times). Combined
organic layers were concentrated and purified by silica gel
column chromatography [eluent: chloroform-EtOH (0-3%)].
Appropriate fractions of F AST-8 and SLOW-8 were collected
and concentrated to give pure 8 as colorless foams.
5′-O-DMT-N4-ben zoyl-2′-d eoxycytid in e 3′-O-(S-Meth yl
m eth a n ep h osp h on oth iola te) (5, R ) DMT, B ) CBz).
SLOW-[Rp ] was obtained from F AST-7 (R ) DMT, B ) CBz
)
(0.82 g, 1 mmol): yield 82% (0.67 g); 31P NMR δ 55.41; 1H NMR
δ 1.82 (d, 15.6, 3H, PCH3), 2.21 (d, 13.2, 3H, SCH3), 2.92 (m,
2H, H2′, H2′′), 3.48 (m, 2H, H5′, H5′′), 4.31 (d, 3.0, 1H, H4′),
5.28 (m, 1H, H3′), 6.39 (t, 12.8, 1H, H1′); HR FAB-MS found
[M - CH3] 726.204 (calcd 726.203). F AST-(SP ) was obtained
from SLOW-7 (R ) DMT, B ) CBz) (0.82 g, 1 mmol): yield
80% (0.65 g); 31P NMR δ 55.41; HR FAB- MS found [M - CH3]
726.204.
5′-O-DMT-th ym idin e 3′-O-(Se-m eth yl m eth an eph osph o-
n oselen ola te). (4′, R ) DMT, B ) Thy) was obtained from 9
(R ) DMT, B ) Thy) (0.760 g, 1 mmol). Total yield of both
isomers (RP) and (SP): 86%. SLOW-(RP ): yield 40%; 31P NMR
δ 49.76 (1J P-Se ) 430 Hz); 1H NMR δ 1.91 (d, 15.1, 3H, PCH3),
2.16 (d, 11.5, 3H, SeCH3); HR FAB-MS found [M - CH3]
685.124 (calcd [M - CH3] 685.140). F AST-(SP ): yield 46%;
31P NMR δ 49.72 (1J P-Se ) 428 Hz); 31P NMR δ 1.93 (d, 15.2,
3H, PCH3), 2.18 (d, 11.6, 3H, PSeCH3); HR FAB-MS found
[M - CH3] 685.124.
5′-O-DMT-t h ym id in e 3′-O-m et h a n ep h osp h on oa n ili-
d a te (8) was obtained from 5′-O-DMT-thymidine (0.54 g, 1
mmol) and purified and separated by column chromatography
(CHCl3-2% EtOH), total yield 91%. F AST-(RP ): yield 45%;
31P NMR δ 30.52; 1H NMR δ 1.66 (d, 16.9, 3H, PCH3), 2.31
(dd, 5.7, 14.3, 1H, H2′), 2.47 (dd, 6.5, 13.7, 1H, H2′), 3.50 (m,
2.3, 2.4, 2H, H5′, H5′′), 6.47 (dd, 8.9, 9.0, 1H, H1′); HR FAB-
MS found [M - H] 696.244 (calcd 696.247). SLOW-(SP ): yield
1
45%; 31P NMR δ 30.12; H NMR δ 1.70 (d, 16.9, 3H, PCH3),
5′-O-DMT-N4-ben zoyl-2′-d eoxycytid in e 3′-O-(Se-Meth yl
2.40 (m, 6.1, 14.6, 1H, H2′′), 2.76 (m, 5.4, 13.8, 1H, H2′′), 3.27
(dd, 10.7, 2.9, 1H, H5′), 4.02 (dd, 10.6, 2.6, 1H, H5′′), 6.52 (dd,
8.9, 9.0, 1H, H1′); HR FAB- MS found [M - H] 696.244 (calcd
696.247).
m eth a n ep h osp h on oselen ola te) (4′, R ) DMT, B ) CBz).
SLOW-(RP ) was obtained from F AST-9 (R ) DMT, B ) CBz
)
1
(1 mmol): yield 70%; 31P NMR δ 49.76 (1J P-Se ) 430 Hz); H
NMR δ 1.92 (d, 15.1, 3H, PCH3), 2.15 (d, 11.6, 3H, SeCH3),
2.40 (m, 1H, H2′), 2.95 (n, 1H, H2′′), 3.50 (m, 2H, H5′, H5′′),
4.32 (dd, 2.9, 1H, H3′), 5.31 (m, 1H, H4′), 6.41 (dd, 6.3, 6.4,
1H, H1′); HR FAB-MS found [M - H] 788.159 (calcd 788.164).
5′-O-DMT-N4-ben zoyl-2′-d eoxycytid in e 3′-O-m eth a n e-
p h osp h on oa n ilid a te (8) was obtained from 5′-O-DMT-N4-
benzoyl-2′-deoxycytidine (0.63 g, 1 mmol) and purified and
separated into diastereomers by single column chromatogra-
phy (CHCl3-3% EtOH), total yield 90%. F AST-(RP ): yield
F AST-(SP ) was obtained from SLOW-9 (R ) DMT, B ) CBz
)
1
(1 mmol): yield 72%; 31P NMR δ 49.72 (1J P-Se ) 428 Hz); H
NMR δ 1.92 (d, 15.1, 3H, PCH3), 2.19 (d, 11.6, 3H, SeCH3),
2.38 (m, 1H, H2′), 2.95 (m, 1H, H2′′), 3.44 (dd, 3.3, 11.3, 1H,
1
45%; 31P NMR δ 30.12; H NMR δ 1.51 (d, 16.5, 3H, PCH3),
2.13 (m, 1H, H2′), 2.36 (1H, H2′′), 3.17 (m, 2H, H5′, H5′′), 4.18